chr2-208437603-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_005048.4(PTH2R):c.245C>A(p.Ser82Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0178 in 1,613,320 control chromosomes in the GnomAD database, including 316 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.012 ( 18 hom., cov: 32)
Exomes 𝑓: 0.018 ( 298 hom. )
Consequence
PTH2R
NM_005048.4 stop_gained
NM_005048.4 stop_gained
Scores
1
6
Clinical Significance
Conservation
PhyloP100: -0.0960
Genes affected
PTH2R (HGNC:9609): (parathyroid hormone 2 receptor) The protein encoded by this gene is a member of the G-protein coupled receptor 2 family. This protein is a receptor for parathyroid hormone (PTH). This receptor is more selective in ligand recognition and has a more specific tissue distribution compared to parathyroid hormone receptor 1 (PTHR1). It is activated only by PTH and not by parathyroid hormone-like hormone (PTHLH) and is particularly abundant in brain and pancreas. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 2-208437603-C-A is Benign according to our data. Variant chr2-208437603-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 3056501.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0121 (1845/152146) while in subpopulation NFE AF= 0.021 (1425/67992). AF 95% confidence interval is 0.0201. There are 18 homozygotes in gnomad4. There are 805 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 18 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PTH2R | NM_005048.4 | c.245C>A | p.Ser82Ter | stop_gained | 3/13 | ENST00000272847.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PTH2R | ENST00000272847.7 | c.245C>A | p.Ser82Ter | stop_gained | 3/13 | 1 | NM_005048.4 | P1 | |
PTH2R | ENST00000617735.4 | c.-89C>A | 5_prime_UTR_variant | 3/13 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0121 AC: 1844AN: 152030Hom.: 18 Cov.: 32
GnomAD3 genomes
AF:
AC:
1844
AN:
152030
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0119 AC: 2981AN: 250978Hom.: 30 AF XY: 0.0120 AC XY: 1633AN XY: 135738
GnomAD3 exomes
AF:
AC:
2981
AN:
250978
Hom.:
AF XY:
AC XY:
1633
AN XY:
135738
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0183 AC: 26806AN: 1461174Hom.: 298 Cov.: 31 AF XY: 0.0177 AC XY: 12869AN XY: 726836
GnomAD4 exome
AF:
AC:
26806
AN:
1461174
Hom.:
Cov.:
31
AF XY:
AC XY:
12869
AN XY:
726836
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0121 AC: 1845AN: 152146Hom.: 18 Cov.: 32 AF XY: 0.0108 AC XY: 805AN XY: 74374
GnomAD4 genome
AF:
AC:
1845
AN:
152146
Hom.:
Cov.:
32
AF XY:
AC XY:
805
AN XY:
74374
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
81
ALSPAC
AF:
AC:
78
ExAC
AF:
AC:
1525
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PTH2R-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 09, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MutationTaster
Benign
A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 44
Find out detailed SpliceAI scores and Pangolin per-transcript scores at